“Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment Histopathology Pathway for Lesions Clinically Suspicious for Melanoma”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 2, Mar. 2022, pp. 109-21, https://doi.org/10.25251/skin.6.2.4.